TuHURA Biosciences, Inc. (HURA)
NASDAQ: HURA · Real-Time Price · USD
1.410
-0.210 (-12.96%)
At close: Apr 2, 2026, 4:00 PM EDT
1.460
+0.050 (3.52%)
After-hours: Apr 2, 2026, 7:26 PM EDT

TuHURA Biosciences Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2024FY 2024FY 2023
Period Ending
Dec '25 Dec '24 Jun '24 Dec '23 Jun '23
Selling, General & Admin
7.583.87-4.14-
Research & Development
20.5313.34-25.62-
Other Operating Expenses
3.680.44---
Total Operating Expenses
31.817.65029.760
Operating Income
-31.8-17.65--29.76-
Interest Income
-0.14-0.36--0.09-
Interest Expense
-0.63-4.14--0.02-
Other Non-Operating Income (Expense)
0.58-0.37--0.38-
Total Non-Operating Income (Expense)
-0.18-4.87--0.49-
Pretax Income
-31.98-22.52--30.25-
Net Income
-30.06-22.65-8.5-29.32-15.02
Net Income Attributable to Preferred Dividends
-0.01-0.97-0.18--0.37
Net Income to Common
-30.06-22.65-8.5-29.32-15.02
Shares Outstanding (Basic)
4819110
Shares Outstanding (Diluted)
4819110
Shares Change (YoY)
156.81%2378.73%-1526.67%-
EPS (Basic)
-0.63-1.21-11.20-2.47-324.45
EPS (Diluted)
-0.63-1.21-11.20-2.47-324.45
Shares Outstanding
59.3413.6512.170.360.06
Free Cash Flow
-27.71-14.79-7.2-12.03-12.1
Free Cash Flow Per Share
-0.58-0.79-9.56-15.98-261.35
EBITDA
-31.72-17.530.06-29.593.29
EBIT
-31.8-17.65--29.76-
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q